JUPITER NEUROSCIENCES, INC.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
JUNS$2.22+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements Of Changes In Stockholders’ Equity (Deficit)
(Unaudited)
| Common Stock · Additional Paid · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | in Capital | Deficit | Deficit | |
| December 31, 2024 | 33,103,860 | $3,310 | $30,190,827 | $(26,022,129) | $4,172,008 |
| Stock-based compensation | - | - | 421,454 | - | 421,454 |
| Net operating loss | - | - | - | (1,528,867) | (1,528,867) |
| March 31, 2025 | 33,103,860 | $3,310 | $30,612,281 | $(27,550,996) | $3,064,595 |
| Common Stock · Additional Paid · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | in Capital | Deficit | Deficit | |
| December 31, 2025 | 34,446,455 | $3,444 | $32,831,730 | $(34,667,026) | $(1,831,852) |
| Stock-based compensation | - | - | 454,242 | - | 454,242 |
| Shares issued for exercise of stock options | 675,000 | 68 | 5,439 | - | 5,507 |
| Issuance of common stock for payment of notes and interest | 995,975 | 100 | 496,291 | - | 496,391 |
| Shares issued for conversion of convertible notes | 113,922 | 11 | 107,452 | - | 107,463 |
| Shares issued for service agreement | 50,000 | 5 | 46,745 | - | 46,750 |
| Net operating loss | - | - | - | (2,061,958) | (2,061,958) |
| March 31, 2026 | 36,281,352 | $3,628 | $33,941,899 | $(36,728,984) | $(2,783,457) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.